
Renoprotective Effects of Febuxostat and Allopurinol in Patients with Hyperuricemia and CKD: A Meta-analysis
This paper was presented on October 23rd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference

This paper was presented on October 23rd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference

This paper was presented on October 23rd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference

This paper was presented on October 23rd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference

Switching to sucroferric oxyhydroxide from other phosphate binders might decrease hospital admissions among patients with persistent hyperphosphatemia, according to new

The neutrophil-to-lymphocyte ratio (NLR) may predict morbidity and mortality in patients with community-acquired acute kidney injury (AKI), investigators reported at

Kidney transplant recipients (KTRs) hospitalized for COVID-19 have high rates of death and acute kidney injury (AKI), according to separate

Previous research has found that dyslipidemia may be a risk factor for new-onset chronic kidney disease (CKD). Now new study

People living with HIV (PLWH) who are hospitalized with COVID-19 have a high incidence of acute kidney injury (AKI), and

Potassium intake from foods does not appear to predispose patients receiving hemodialysis (HD) to hyperkalemia or lead to death, according

This paper was presented on October 22nd 2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference